Ranked after the close on October 30, 2026
Drug Manufacturers - Specialty & Generic stocks
Drug Manufacturers - Specialty & Generic ranks #21 of 140 industry groups, one of the market's strongest groups, with a median 6-month return of +14% across its 34 US stocks above $1B (sector: Healthcare). AMRX is in today's top 50 leaders.
#21group rank of 140
+14%median, 6 months
34stocks above $1B
1in the top 50
Drug Manufacturers - Specialty & Generic stocks ranked
| # | Stock | Market cap | Off high | Comp | EPS | RS |
|---|---|---|---|---|---|---|
| 1 | AMRX Top 50Amneal Pharmaceuticals, Inc. | $7.5B | 0.8% | |||
| 2 | CRONCronos Group Inc. Common Share | $1.2B | 8.5% | |||
| 3 | ETONEton Pharmaceuticals, Inc. | $1.5B | 21.4% | |||
| 4 | KNSAKiniksa Pharmaceuticals Interna | $7.2B | 6.3% | |||
| 5 | PCRXPacira BioSciences, Inc. | $1.5B | 0.8% | |||
| 6 | BHCBausch Health Companies Inc. | $3.1B | 9.3% | |||
| 7 | UTHRUnited Therapeutics Corporation | $25.7B | 1.8% | |||
| 8 | INDVIndivior Pharmaceuticals, Inc. | $4.2B | 17.4% | |||
| 9 | BCRXBioCryst Pharmaceuticals, Inc. | $2.2B | 24.5% | |||
| 10 | LNTHLantheus Holdings, Inc. | $6.6B | 10.2% | |||
| 11 | AMPHAmphastar Pharmaceuticals, Inc. | $1.2B | 6.1% | |||
| 12 | PRGOPerrigo Company plc | $2.2B | 24.9% | |||
| 13 | HCMHUTCHMED (China) Limited | $2.3B | 19.5% | |||
| 14 | AMLXAmylyx Pharmaceuticals, Inc. | $3.6B | 29.8% | |||
| 15 | TEVATeva Pharmaceutical Industries | $49.1B | 1.2% | |||
| 16 | XERSXeris Biopharma Holdings, Inc. | $2.0B | 6.2% | |||
| 17 | ANIPANI Pharmaceuticals, Inc. | $1.7B | 24.7% | |||
| 18 | LQDALiquidia Corporation | $4.0B | 51.9% | |||
| 19 | NBIXNeurocrine Biosciences, Inc. | $14.9B | 21.5% | |||
| 20 | PAHCPhibro Animal Health Corporatio | $1.6B | 35.3% | |||
| 21 | VTRSViatris Inc. | $21.9B | 2.4% | |||
| 22 | TAKTakeda Pharmaceutical Company L | $66.8B | 1.5% | |||
| 23 | ALKSAlkermes plc | $7.6B | 18.6% | |||
| 24 | RDYDr. Reddy's Laboratories Ltd | $11.8B | 9.6% | |||
| 25 | HLNHaleon plc | $38.1B | 23.2% | |||
| 26 | ELANElanco Animal Health Incorporat | $11.5B | 17.6% | |||
| 27 | TRLVTrulieve Cannabis Corp. Subordi | $2.0B | 22.6% | |||
| 28 | ALVOAlvotech | $1.7B | 40.5% | |||
| 29 | PBHPrestige Consumer Healthcare In | $2.3B | 31.0% | |||
| 30 | ZTSZoetis Inc. | $32.9B | 45.0% | |||
| 31 | RGCRegencell Bioscience Holdings L | $3.3B | 90.3% | |||
| 32 | HIMSHims & Hers Health, Inc. | $6.5B | 42.7% | |||
| 33 | SUPNSupernus Pharmaceuticals, Inc. | $2.4B | 29.8% | |||
| 34 | HROWHarrow, Inc. | $1.1B | 48.5% |
In order of their Comp rating. The ratings themselves, and the same day's ranking, are for members. Sign in or start for €6.99 a month.
See every rating for €6.99 a month